Drug Approval | September 06, 2021
Alembic JV Aleor receives US FDA final approval for skin disorder gel
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
According to WHO, over 1.5 million people died of TB in 2020
In March 2016, Dr. Reddy’s had acquired the exclusive global rights (excluding Japan and Asia) to the investigational anti-cancer agent E7777 from Eisai Co.
The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
The company has been sold to Shinshin Pharmaceuticals
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
The clinical trial will evaluate the safety, tolerability and pharmacokinetic properties of ICP-723 in patients with solid tumours, and evaluate the anti-tumour efficacy of ICP-723 on NTRK fusion-positive cancers
Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP are available in one strength of 5 mg/2.5 mg capsules in bottle count sizes of 100
Subscribe To Our Newsletter & Stay Updated
